Day Trading Solutions

Stock Option Trading By Staff

FDA warning The Food and Drug Administration (FDA) has put out a bolded warning for severe liver injury after taking Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and children. The labeling warns that severe liver injury may progress to liver failure resulting in death or the need for a liver transplant in a small percentage of patients. marketing adverse events.

Currency Day Trading (AXcess News) Landover, MD - A watchdog group for people suffering from attention-deficit/hyperactivity disorder responded with concern to last week's recommendation by an FDA Advisory committee that warning language be included on ADHD medication labels.

Public Citizen, a Washington, D.C.- profit consumer advocacy group, officially petitioned the FDA to take Crestor off the market in March. To no one’s surprise, the FDA denied the group's request, but required the drug to carry a revised warning label to emphasize the risk of muscle damage. At the time, Dr. Sidney Wolfe, head of Public Citizen's Health Research Group, said that "once again, when faced with concerns about the safety of a drug, the FDA has sided with the drug's maker, AstraZeneca, instead of the public."

Financial Software Trading The nation's largest patient education group, Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) represents more than 15,000 people affected by attention-deficit/hyperactivity disorder (ADHD) and provides consumer, patient, professional and organizational information and support and manages the National Resource Center on ADHD, funded by the U.S. Centers for Disease Control and Prevention.

(AXcess NEws) The Food and Drug Administration (FDA) is requiring the maker's of Paxil, an antidepressant, to include a warning of suicide risks in young adults on its labeling for doctors and patients prescribed the medication. The FDA and GlaxoSmithKline, Plc ( GSK)the makers of Paxil and Paxil CR, the controlled release version of the antidepressant drug, are both notifying doctors about the warning, which is being added to the drug's package inserts.

Online Stock Trading Company "The committee's recommendation to include warning language about rare and unproven cardiac health risks on medications used to treatADHD is premature, at best, and could unnecessarily alarm patients and clinicians," said E. Clarke Ross, D.P.A., CEO of CHADD, a Landover, Md., based advocacy and support group.

The news media have humiliated FDA officials who are unable to point to a single case of harm occurring to anyone who has ever imported a drug from Canada or Europe. Despite losing more credibility each day, the FDA continues its cruel farce by issuing warnings about the purported dangers of offshore drugs. The sidebar on the next page is an excerpt of a warning that appears on the FDA website (www.fda.gov).

Forex Day Trading "As an organization that relies on scientific research and evidence-based treatment for this disorder, CHADD views the committee's recommendation as unwarranted and unnecessarily alarming for physicians and patients alike," he said.

The agency is directing manufacturers to add a "black box" warning to the health professional labeling of all antidepressant medications to describe this risk and emphasize the need for close monitoring of patients started on these medications. FDA has also determined that a Patient Medication Guide (MedGuide), which will be given to patients receiving the drugs to advise them of the risk and precautions that can be taken, is appropriate, and is in the process of developing one.

Financial In Market On Thursday, Feb. 9 the FDA Drug Safety and Risk Management Advisory Committee voted 8-7 with one abstention to recommend "black box" warnings about possible risk of heart attacks, strokes and sudden death. No conclusive link between the medications and such health problems has been found, a point underscored by testimony offered by a medical officer in the FDA Office of Drug Safety. Kate Gelperin, M.D., M.P.H., testified that the agency's own studies found no definitive relationship between the medications and the reported incidents in children and adults.

Stock Trading System The committee, directed by the FDA to decide how to move ahead with additional research on the medication's safety, endorsed future studies, trials and surveys for both pediatric and adult patients, and then approved the unsolicited recommendation to include warning language on patient inserts and labels.

Day Trading Stock Tip "We absolutely support the need for further research," Dr. Ross said. "But by recommending warning language without first studying the issue, the committee has sent doctors and their patients an alarming message that is not supported by science."

Financial Forex Forex Software The organization urged patients to consult with their prescribing clinicians if they had questions about the safety of their medications; people taking medications were advised not to discontinue those treatments without first communicating with their doctors.

Stock Market Trading The FDA's review of reports of sudden death or cardiovascular incidents in patients taking ADHD medications found 25 reports of death between 1999 and 2005 and 54 incidents of serious cardiovascular problems. Some of these patients had pre-existing heart conditions or hypertension, the report noted.

Day Lesson Stock Tip Trading For many persons, ADHD medications are an important part of a comprehensive treatment program that may include patient education, behavior management techniques, medication and school programming and support, with treatment tailored to the unique needs of the individual. According to a December 1999 report from the Surgeon General, medication is effective for about 80 percent of people who have the disorder. About 2.5 million children between the ages of 4 and 17 take ADHD medications, according to CDC data. Millions of children and adults have successfully used these medications in recent years, and the many positive benefits, as demonstrated in dozens of studies, speak for themselves. All medications can cause side-effects, and CHADD encourages individuals to share concerns and preexisting conditions with their health care providers.

[ Comment, Edit or Article Submission ]